ISIN | LU1811047593 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Bellevue Digital Health B Cap |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies whose business activities have a strong focus on the digitisation of the health sector or whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without limiting the scope of the term Digital Health, businesses in the digital health sector comprise companies that are in a good position in the segments of diagnostics, healthcare IT, life sciences tools, medical technology, healthcare service providers or wellness to be able to benefit from the advent of digital technologies. |
Peculiarities |
Current Price * | 170.08 USD | 01.04.2025 |
---|---|---|
Previous Price * | 170.42 USD | 31.03.2025 |
52 Week High * | 198.35 USD | 19.02.2025 |
52 Week Low * | 161.55 USD | 19.04.2024 |
NAV * | 170.08 USD | 01.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 218,175,146 | |
Unit/Share Assets *** | ||
Trading Information SIX |
YTD Performance | -5.19% |
31.12.2024 - 01.04.2025
31.12.2024 01.04.2025 |
---|---|---|
YTD Performance (in CHF) | -7.73% |
31.12.2024 - 01.04.2025
31.12.2024 01.04.2025 |
1 month | -7.78% |
03.03.2025 - 01.04.2025
03.03.2025 01.04.2025 |
3 months | -5.64% |
02.01.2025 - 01.04.2025
02.01.2025 01.04.2025 |
6 months | -6.55% |
01.10.2024 - 01.04.2025
01.10.2024 01.04.2025 |
1 year | +1.05% |
02.04.2024 - 01.04.2025
02.04.2024 01.04.2025 |
2 years | -8.77% |
03.04.2023 - 01.04.2025
03.04.2023 01.04.2025 |
3 years | -22.77% |
01.04.2022 - 01.04.2025
01.04.2022 01.04.2025 |
5 years | +17.73% |
01.04.2020 - 01.04.2025
01.04.2020 01.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Insulet Corp | 9.24% | |
---|---|---|
Intuitive Surgical Inc | 9.06% | |
DexCom Inc | 7.47% | |
PROCEPT BioRobotics Corp | 5.65% | |
Penumbra Inc | 5.38% | |
Privia Health Group Inc | 4.71% | |
Natera Inc | 4.56% | |
Globus Medical Inc Class A | 4.43% | |
Ambu AS Class B | 4.34% | |
Exact Sciences Corp | 4.32% | |
Last data update | 28.02.2025 |
TER | 2.21% |
---|---|
TER date | 01.02.2021 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 2.15% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |